A Drug-Drug Interaction Study of HDM1002 and Metformin, Empagliflozin, Midazolam, Valsartan, and Warfarin

Clinical trial NCT07331389 · RECRUITING

Trial details

NCT number: NCT07331389
Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Overweight Subject Healthy Subjects

Start date: 2025-09-24
Primary completion: 2026-01-12
Enrollment: 111

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.